In December 2015, the Patented Medicine Prices Review Board (PMPRB) posted a Notice and Comment seeking stakeholder comments on the following proposed changes:

• Reasonable Relationship Test (Schedule 4) Amendment
• List Price relative to Maximum Average Potential Price (MAPP) Verification (Section C.11) Amendment

Subsequent to stakeholder feedback received during the public comment period, the PMPRB will not be implementing the changes to the Compendium of Policies, Guidelines and Procedures. The PMPRB is continuing the review of the comments received and will announce next steps in June 2016 following the Board’s final decisions regarding the proposed amendments.